Citadel Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$262M Sell
743,500
-74,500
-9% -$26.6M 0.04% 345
2025
Q4
$268M Sell
818,000
-493,400
-38% -$157M 0.04% 376
2025
Q3
$370M Sell
1,311,400
-73,500
-5% -$21.3M 0.06% 264
2025
Q2
$387M Sell
1,384,900
-31,300
-2% -$8.87M 0.07% 211
2025
Q1
$441M Sell
1,416,200
-259,300
-15% -$76.6M 0.08% 154
2024
Q4
$437M Buy
1,675,500
+660,800
+65% +$196M 0.08% 179
2024
Q3
$327M Sell
1,014,700
-417,400
-29% -$137M 0.06% 222
2024
Q2
$447M Buy
1,432,100
+283,600
+25% +$83.3M 0.09% 142
2024
Q1
$327M Buy
1,148,500
+246,200
+27% +$72M 0.06% 221
2023
Q4
$260M Sell
902,300
-18,100
-2% -$4.93M 0.05% 258
2023
Q3
$247M Buy
920,400
+119,500
+15% +$29.8M 0.05% 245
2023
Q2
$178M Sell
800,900
-56,000
-7% -$13M 0.04% 361
2023
Q1
$207M Buy
856,900
+116,800
+16% +$28.7M 0.05% 308
2022
Q4
$194M Sell
740,100
-569,700
-43% -$153M 0.05% 342
2022
Q3
$295M Sell
1,309,800
-35,000
-3% -$8.48M 0.07% 186
2022
Q2
$327M Buy
1,344,800
+42,800
+3% +$10.5M 0.08% 156
2022
Q1
$315M Buy
1,302,000
+667,300
+105% +$153M 0.07% 196
2021
Q4
$143M Sell
634,700
-250,600
-28% -$52.9M 0.03% 482
2021
Q3
$188M Buy
885,300
+162,900
+23% +$37.5M 0.04% 366
2021
Q2
$176M Buy
722,400
+287,300
+66% +$70.7M 0.04% 372
2021
Q1
$108M Sell
435,100
-49,900
-10% -$11.9M 0.03% 550
2020
Q4
$112M Sell
485,000
-55,300
-10% -$12.7M 0.03% 490
2020
Q3
$137M Buy
540,300
+170,900
+46% +$42.3M 0.04% 313
2020
Q2
$87.1M Sell
369,400
-161,800
-30% -$36.9M 0.03% 473
2020
Q1
$108M Buy
531,200
+25,000
+5% +$5.46M 0.05% 310
2019
Q4
$122M Sell
506,200
-60,100
-11% -$13.2M 0.05% 326
2019
Q3
$110M Sell
566,300
-7,100
-1% -$1.36M 0.05% 360
2019
Q2
$106M Buy
573,400
+17,200
+3% +$3.08M 0.05% 378
2019
Q1
$106M Sell
556,200
-132,400
-19% -$25.3M 0.05% 343
2018
Q4
$134M Sell
688,600
-92,900
-12% -$18.1M 0.07% 232
2018
Q3
$162M Buy
781,500
+111,000
+17% +$21.9M 0.07% 242
2018
Q2
$124M Buy
670,500
+162,400
+32% +$28.7M 0.06% 292
2018
Q1
$86.6M Buy
508,100
+140,800
+38% +$25.8M 0.05% 377
2017
Q4
$63.9M Sell
367,300
-35,800
-9% -$6.34M 0.04% 504
2017
Q3
$75.2M Sell
403,100
-46,200
-10% -$8.19M 0.06% 349
2017
Q2
$77.4M Sell
449,300
-30,800
-6% -$5.01M 0.07% 311
2017
Q1
$78.8M Buy
480,100
+90,600
+23% +$15.1M 0.07% 264
2016
Q4
$56.9M Buy
389,500
+116,300
+43% +$17.5M 0.06% 331
2016
Q3
$45.6M Buy
273,200
+1,100
+0.4% +$186K 0.05% 428
2016
Q2
$41.4M Buy
272,100
+46,000
+20% +$7.15M 0.05% 422
2016
Q1
$33.9M Sell
226,100
-57,900
-20% -$8.6M 0.04% 452
2015
Q4
$46.1M Sell
284,000
-68,600
-19% -$10.8M 0.05% 427
2015
Q3
$48.8M Buy
352,600
+65,900
+23% +$10.4M 0.05% 451
2015
Q2
$44M Buy
286,700
+43,000
+18% +$6.89M 0.04% 564
2015
Q1
$39M Buy
243,700
+21,000
+9% +$3.31M 0.04% 599
2014
Q4
$35.5M Sell
222,700
-6,700
-3% -$1.04M 0.03% 644
2014
Q3
$32.2M Buy
229,400
+115,500
+101% +$15.1M 0.03% 628
2014
Q2
$13.5M Sell
113,900
-158,600
-58% -$18.4M 0.02% 1055
2014
Q1
$33.6M Buy
272,500
+7,500
+3% +$910K 0.04% 564
2013
Q4
$30.3M Sell
265,000
-49,200
-16% -$5.6M 0.04% 585
2013
Q3
$35.2M Buy
314,200
+71,000
+29% +$7.7M 0.05% 450
2013
Q2
$24M Buy
+243,200
New +$25.2M 0.04% 562

Other funds holding AMGN

Citadel Advisors's AMGN Position: Q1 2026 in Review

Citadel Advisors increased its Amgen (AMGN) stake by 54% in Q1 2026, buying an estimated $23.2M and bringing the position to 184,963 shares worth $65.1M. The position accounts for 0.01% of the portfolio, ranked #1127.

Citadel Advisors first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $230M in Q2 2020. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Citadel Advisors held 184,963 shares of Amgen worth $65.1M as of Q1 2026.
  • Citadel Advisors bought 64,983 Amgen shares in Q1 2026, an estimated $23.2M.
  • Amgen made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1127 holding.
  • Citadel Advisors first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Citadel Advisors's Amgen position peaked at $230M in Q2 2020.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.